Navigation Links
Onyx Pharmaceuticals Provides Update on Carfilzomib at 53rd American Society of Hematology Annual Meeting
Date:12/10/2011

on a Special Protocol Assessment (SPA) on the design and planned analysis of the ASPIRE trial.
  • A Phase 3 clinical trial, called the FOCUS trial to support registration in Europe, is evaluating single-agent carfilzomib in patients with relapsed and refractory myeloma who have received three or more prior therapies.
  • An expanded access program is underway in partnership with the Multiple Myeloma Research Foundation for eligible patients in the U.S., with relapsed and refractory multiple myeloma for whom no satisfactory treatment alternatives are available.
  • About Multiple Myeloma
    Multiple myeloma is the second most common hematologic cancer and results from an abnormality of plasma cells, usually in the bone marrow. In the United States, more than 50,000 people are living with multiple myeloma and approximately 20,000 new cases are diagnosed annually.[ii] Worldwide, more than 180,000 people are living with multiple myeloma and approximately 86,000 new cases are diagnosed annually.[iii]

    About Onyx Pharmaceuticals, Inc.
    Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases.  The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx-pharm.com.

    Forward Looking Statements
    This news release contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding the progress and results of the clinical development, the expanded access program, safety, regulatory processes, commercialization efforts or commercial potential of carf
    '/>"/>

    SOURCE Onyx Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Radient Pharmaceuticals Submits an Abstract to the American Society of Colon and Rectal Surgeons
    2. Arena Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference
    3. Webcast Alert: Isis Pharmaceuticals Holds Webcast to Discuss Recent Additions to its Development Pipeline
    4. Survival Benefit With Syndax Pharmaceuticals Entinostat Maintained in Women with Advanced Breast Cancer
    5. Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™
    6. Inovio Pharmaceuticals Closes $4.0 Million Underwritten Financing
    7. Onyx Pharmaceuticals to Host a Teleconference to Reprise Key Data From the American Society of Hematology Meeting
    8. Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call
    9. Anthera Pharmaceuticals Promotes Dr. Debra Odink to Chief Technology Officer
    10. Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology
    11. Radient Pharmaceuticals Two Abstracts Submitted to 2012 Gastrointestinal Cancers Symposium (ASCO) Regarding Onko-Sure® Utility in Colorectal Cancer Are Accepted for Presentation
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
    (Date:12/17/2014)... Ga. and RALEIGH, N.C. ... Trial Marketing Communications, LLC (CTMC), and Integrated Clinical ... patient recruitment and retention for clinical trials announce ... Integrated Clinical Trial Marketing Services (i-CTMS). i-CTMS will ... retention services to pharmaceutical, biotechnology and medical device ...
    (Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "MEMS Gyroscopes Analog ... Analysis" report to their offering. ... gyroscopes for tactical grade applications made a lot ... term of reliability. They are now accepted in ...
    Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2
    ... and economic advantages of nifedipine,GITS therapy , ... 2007 – Two recently,published articles in the ... the use of the long-acting calcium channel,blocker ... beyond its blood pressure lowing effect. A ...
    ... Interleukin,Genetics, Inc. (AMEX:ILI) and collaborators at the ... the American College of,Cardiology annual meeting that ... oxidized phospholipids (OxPL) and Lp(a),levels appear to ... (IL-1) genes., In a presentation titled "The ...
    Cached Medicine Technology:Calcium Channel Blocker Adalat GITS Offer Additional Benefits 2Calcium Channel Blocker Adalat GITS Offer Additional Benefits 3ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 2ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 3
    (Date:12/19/2014)... Randy Dotinga ... News) -- Common painkillers, including ibuprofen, might slightly reduce ... researchers say. Use of ibuprofen (Advil, Motrin) and ... cell skin cancer by 15 percent, the researchers concluded ... is usually caused by sun exposure. ...
    (Date:12/17/2014)... While countless companies tempt patients to ... potential dangers of their purchase. Not only is the sale ... doctor, but patients who buy hCG online are typically receiving ... actually no real hCG present. Illegal internet hCG is typically ... safety standards and may contain unknown fillers that can pose ...
    (Date:12/17/2014)... 2014 HeartMath® Inc., recognized as ... heart rate variability (HRV), heart coherence and the ... HRV databases and algorithms to chipset manufacturers and ... HeartMath’s partners to offer its HRV solutions, tap ... well as its normative HRV databases and algorithms ...
    (Date:12/17/2014)... Now in its second year, the SeniorAdvisor.com ... best in senior living and home care across the ... and agencies that have received outstanding online feedback from ... 100,000 providers currently listed on SeniorAdvisor.com, only 879 were ... of 2015 Awards are located all over the country ...
    (Date:12/17/2014)... 2014 (HealthDay News) -- Expectant parents should leave prenatal ... Administration recommends. Use of ultrasound imaging and heartbeat ... entirely risk-free, the agency warns. "Although there ... to ultrasound imaging and heartbeat monitors, prudent use of ... Shahram Vaezy, an FDA biomedical engineer, said in an ...
    Breaking Medicine News(10 mins):Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 2Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 3Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 2Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 3Health News:FDA Warns Against Fetal 'Keepsake' Videos 2
    ... about his health care plan to SpineUniverse.com, whose recent survey results ... ... Montclair, NJ (PRWEB) October 31, 2008 -- Senator Barack ... care plan to SpineUniverse.com. Now every visitor to SpineUniverse.com -- ...
    ... The art and science of hormone,balancing vs. hormone replacement ... believe that breast cancer and its risks can be ... the landmark book, "What Your Doctor May Not Tell ... Your Life", nearly all risk,factors associated with breast cancer ...
    ... cancer related to HBV viral infection in Asian countries, ... treated by surgical resection including liver transplantation and non-surgical ... lung, so called lung metastasis from liver cancer is ... are very advanced and too late in being adequately ...
    ... for a Healthy Pet(R), contest sponsored by Morris,Animal ... DENVER, Oct. 31 Veterinarians provide our pets ... healthy and happy lives. To,recognize their efforts, hundreds ... "Thank Your Vet for a Healthy Pet(R)" contest, ...
    ... 31 A new report shows many are ... Here,s more on ways to get the,most out ... staying healthy., Listen to this report ... can access video, audio, text, graphics and,photos for ...
    ... WASHINGTON, Oct. 31 In the final 72-hours ... other volunteers,across the country are joining 4,000 SEIU ... off the job to bring home victory for,Barack ... change working,families need., SEIU,s major GOTV operations ...
    Cached Medicine News:Health News:Senator Obama Explains His Health Care Plan to SpineUniverse.com 2Health News:Senator Obama Explains His Health Care Plan to SpineUniverse.com 3Health News:Natural Hormone Balance: Gaining Ground in the Fight Against Breast Cancer 2Health News:If metastasectomy should be performed before other treatments 2Health News:Hundreds of Pet Owners Nominate Veterinarians in Nationwide Contest to Find America's Best Vet 2Health News:Hundreds of Pet Owners Nominate Veterinarians in Nationwide Contest to Find America's Best Vet 3Health News:In Final 72-Hour Push, SEIU Members Get Out The Vote for Barack Obama and Other Working Family Candidates Across the Country 2
    Low-profile, hand-held instrument....
    Low-profile, hand-held instrument....
    Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
    Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
    Medicine Products: